site logo

FDA breakthrough nods go to liquid biopsies for Alzheimer's, cancer drug response

It gave the designation to Quanterix's blood test, which has the potential to aid evaluation of people who present with cognitive impairment, and Nonagen Bioscience's non-invasive bladder cancer test.

Sarah Silbiger via Getty Images